Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2023-10-12 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI LODR Regulations about a USFDA inspection of the company's wholly-owned subsidiary's facility. It reports the issuance of FDA Form 483 with observations and the company's commitment to compliance. The document is a regulatory announcement informing the stock exchanges about a material event related to compliance and inspection results. It does not contain financial data, audit results, or detailed report content. The document length is short (2204 characters) and serves as an official regulatory disclosure rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. It is a short letter addressed to stock exchanges confirming regulatory compliance, without containing any financial statements or detailed report content. It is primarily a certification document rather than a full financial report or announcement of voting results, management changes, or capital updates. According to the rules, such officer certifications or compliance confirmations fall under Regulatory Filings (RNS). The document length is short (1798 characters), and it does not contain substantive financial data or detailed report content, so it is not an Interim Report or Annual Report. Therefore, the correct classification is Regulatory Filings (RNS).
2023-10-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and depositories providing details of shares dematerialized during September 2023, referencing Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It includes data tables of shares dematerialized and a certificate from the Registrar and Transfer Agent. The document is an official regulatory communication reporting share dematerialization details for record-keeping and compliance purposes. It does not contain financial statements, management discussion, or other report content. It is not an announcement of a report publication but a regulatory filing to stock exchanges and depositories. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters, but it is not merely announcing a report publication; it is the actual regulatory communication with data. Hence, classification as RNS is appropriate with high confidence.
2023-10-06 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It informs about the commencement of an arbitration proceeding involving the company and another party, Apotex Inc. The document provides details of the litigation, the parties involved, the nature of the dispute, and the expected financial implications. There are no financial statements or detailed financial analysis present, only a legal proceeding update. The document is a regulatory announcement about legal proceedings rather than a full legal report or financial report. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length (5523 characters) and content confirm it is not a brief announcement or a certification but a substantive update on litigation.
2023-10-05 English
Shareholders meeting
Regulatory Filings
2023-09-30 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of the 39th Annual General Meeting held on September 29, 2023' and is addressed to stock exchanges referencing SEBI regulations. It details the conduct of the AGM, attendance of directors and auditors, the agenda items including adoption of financial statements, re-appointment of directors, and ratification of remuneration for auditors. It also mentions voting procedures and that voting results will be declared later. The document is a detailed summary of the AGM proceedings rather than the full Annual Report or voting results. It is not a voting results announcement, nor a financial report or earnings release. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including proceedings.
2023-09-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.